Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy
- 1 December 1999
- journal article
- clinical trial
- Published by Wiley in European Journal of Heart Failure
- Vol. 1 (4) , 385-393
- https://doi.org/10.1016/s1388-9842(99)00038-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Angiotensin receptor antagonists: focus on losartanThe Lancet, 1995
- Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin-Converting EnzymeJournal of Cardiovascular Pharmacology, 1995
- Angiotensin II receptor antagonists: A new approach to blockade of the renin-angiotensin systemAmerican Heart Journal, 1994
- Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.Hypertension, 1994
- Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.Journal of Clinical Investigation, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.Circulation, 1981